Literature DB >> 8163515

Semliki Forest virus 6K protein modifies membrane permeability after inducible expression in Escherichia coli cells.

M A Sanz1, L Pérez, L Carrasco.   

Abstract

Semliki Forest virus encodes a small protein, known as 6K, that is associated with cellular membranes in the infected cells. This protein has been cloned and expressed in an inducible manner using pET vectors in Escherichia coli cells. Two different plasmids have been utilized; either the 6K gene is placed directly under the T7 promoter (pET3-6K) or the lac operator is located between the T7 promoter and the 6K gene (pET11-6K). In both systems, efficient synthesis of the 6K protein is achieved by induction with isopropyl-1-thio-beta-D-galactopyranoside plus rifampicin. The synthesis of the 6K protein is very toxic for E. coli causing increased membrane permeability and cell lysis as shown by alterations in permeability to either choline or hygromycin B. These results indicate that the togavirus 6K is a membrane-active protein that shows structural and functional similarities to poliovirus 3A protein. The function that the 6K protein could play during the virus replication cycle is discussed in the light of these findings.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163515

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Subcellular localization and topology of the p7 polypeptide of hepatitis C virus.

Authors:  Séverine Carrère-Kremer; Claire Montpellier-Pala; Laurence Cocquerel; Czeslaw Wychowski; François Penin; Jean Dubuisson
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Restrained expression, a method to overproduce toxic membrane proteins by exploiting operator-repressor interactions.

Authors:  Anoop Narayanan; Marc Ridilla; Dinesh A Yernool
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

Review 3.  Viroporins customize host cells for efficient viral propagation.

Authors:  Kristina M Giorda; Daniel N Hebert
Journal:  DNA Cell Biol       Date:  2013-08-14       Impact factor: 3.311

4.  Rotavirus nonstructural glycoprotein NSP4 alters plasma membrane permeability in mammalian cells.

Authors:  K Newton; J C Meyer; A R Bellamy; J A Taylor
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release.

Authors:  F J van Kuppeveld; J G Hoenderop; R L Smeets; P H Willems; H B Dijkman; J M Galama; W J Melchers
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

6.  Sindbis virus variant with a deletion in the 6K gene shows defects in glycoprotein processing and trafficking: lack of complementation by a wild-type 6K gene in trans.

Authors:  M A Sanz; L Carrasco
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Enhanced intracellular calcium concentration during poliovirus infection.

Authors:  A Irurzun; J Arroyo; A Alvarez; L Carrasco
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  Bovine ephemeral fever rhabdovirus α1 protein has viroporin-like properties and binds importin β1 and importin 7.

Authors:  D Albert Joubert; Kim R Blasdell; Michelle D Audsley; Lee Trinidad; Paul Monaghan; Keyur A Dave; Kim G Lieu; Rachel Amos-Ritchie; David A Jans; Gregory W Moseley; Jeffrey J Gorman; Peter J Walker
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

9.  Functional analyses of GB virus B p13 protein: development of a recombinant GB virus B hepatitis virus with a p7 protein.

Authors:  Shingo Takikawa; Ronald E Engle; Suzanne U Emerson; Robert H Purcell; Marisa St Claire; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

10.  Membrane permeabilization by different regions of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41.

Authors:  J Arroyo; M Boceta; M E González; M Michel; L Carrasco
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.